Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Geller_David_1000x714_ENV

David Geller

Associate

London +44 20 7067 2347

  • About
  • Representative Matters
  • Credentials
  • About

    David Geller is an associate in Covington’s Corporate Practice Group.

    David advises a range of clients on global acquisitions and divestitures, strategic investments and corporate restructurings. He has particular experience in advising on cross-border M&A matters, particularly in the technology and life sciences sectors.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters
    • Advising Renesas Electronics Corporation on its €4.9 billion acquisition of Dialog Semiconductor plc.
    • Representing Elanco in connection a series of antitrust-mandated divestitures in preparation for the $7.6 billion acquisition of Bayer Animal Health. These include an agreement with French pharmaceutical company Vetoquinol to divest the European Economic Area, UK, Canadian and Australian rights to the Drontal and Profender product families for $150 million as well as an agreement with Merck Animal Health to divest the worldwide rights to Elanco's Vecoxan product for $55 million and divestiture of a number of development products.
    • Advising Merck in its global separation of its Organon business in preparation for the $6.5bn spin off of its women's health business.

    Areas of Expertise

  • Credentials
    Education
    • University of the West of England, L.P.C., 2014
    • University of Swansea, LL.B., 2012
        • First Class Honours
    Bar Admissions
    • Solicitor of the Senior Courts of England and Wales

    Areas of Expertise

News and Insights

Events